NCT06234332 Peking University Birth Cohort in Weifang (PKUBC-WF)
| NCT ID | NCT06234332 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University |
| Condition | Health Problems in Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,800 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,800 participants in total. It began in 2024-02-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PKUBC-WF is a prospective cohort study carried out in Weifang city of Shandong, China. The primary aim of this study is to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers and their children from birth to before 18 years old. Biological samples including peripheral blood, urine, placenta, umbilical cord, cord blood, and faeces are also collected.
Eligibility Criteria
Inclusion Criteria: * Pregnant woman 1. Pregnant women, 6-13\^+6 gestational weeks 2. Resided in Weifang in the past half years and have no plan to move out after delivery 3. Pregnant women who plan to have antenatal care and delivery in Weifang maternal\&Child Hospital. 4. Pregnant women who is willing to participate in this study with informed consent * Pregnant woman's husband 1. His wife was eligible for enrollment 2. He is the biological father of the child (his wife's current pregnancy) 3. Pregnant women's husband who is willing to participate in this study with informed consent * Offspring 4. Children born to pregnant women who met the inclusion criteria after enrolling in this study. 5\. Before the age of 8 years, his/her mother provided written informed consent. 6. After 8 years old, he/she agreed to continue this study and signed the informed consent. Exclusion Criteria: * Participants who cannot communicate normally.
Contact & Investigator
Haijun Wang, Ph.D
PRINCIPAL INVESTIGATOR
Peking University
Frequently Asked Questions
Who can join the NCT06234332 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health Problems in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06234332 currently recruiting?
Yes, NCT06234332 is actively recruiting participants. Contact the research team at whjun1@bjmu.edu.cn for enrollment information.
Where is the NCT06234332 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06234332 clinical trial?
NCT06234332 is sponsored by Peking University. The principal investigator is Haijun Wang, Ph.D at Peking University. The trial plans to enroll 2,800 participants.